<?xml version="1.0"?>
<rss version="2.0">
<channel>
<title>Healthcare Industry Today: Cancer News</title>
<link>http://health.einnews.com/news/cancer</link><description>Constantly updated news and information about healthcare industry.</description><item>
<title>Molecular Insight Pharmaceuticals, Inc. To Present Interim Phase 1 Data at ASCO on Azedra(TM) in Malignant Pheochromocytoma/Paraganglioma Patients</title>
<link>http://health.einnews.com/news.php?wid=170205166</link>
<pubDate>16 May 2008 12:33 GMT</pubDate>
<description>
...  radiotherapeutic product candidates, Azedra and Onalta, are being developed for detection and treatment of cancer. The company&apos;s lead molecular imaging pharmaceutical product candidate, Zemiva, is being developed for the  ...
</description>
</item><item>
<title>Genentech Moves Up Study Timing of Avastin in Early-Stage Colon Cancer - Shares Up About 2%</title>
<link>http://health.einnews.com/news.php?wid=170203363</link>
<pubDate>16 May 2008 12:28 GMT</pubDate>
<description>

</description>
</item><item>
<title>Cytokinetics Announces Clinical Trials Data to be Presented at the 2008 Annual Meeting of the American Society of Clinical Oncology</title>
<link>http://health.einnews.com/news.php?wid=170203354</link>
<pubDate>16 May 2008 12:28 GMT</pubDate>
<description>
...  relate to clinical trials evaluating ispinesib that are sponsored by Cytokinetics or the National Cancer Institute (NCI). The third abstract relates to a clinical trial evaluating SB-743921 that is  ...
</description>
</item><item>
<title>Dynavax Tech To Discontinue Tolamba Program</title>
<link>http://health.einnews.com/news.php?wid=170203325</link>
<pubDate>16 May 2008 12:28 GMT</pubDate>
<description>
...  expects to make rapid progress in the clinical testing of its hepatitis C and cancer therapies. ...
</description>
</item><item>
<title>Drug combo, including GSK&apos;s Tykerb, helps women with advanced breast cancer</title>
<link>http://health.einnews.com/news.php?wid=170201624</link>
<pubDate>16 May 2008 11:43 GMT</pubDate>
<description>
... Drug combo, including GSK&apos;s Tykerb, helps women with advanced breast cancer A combination of two new-generation cancer drugs modestly delayed the time it took for  ...
</description>
</item><item>
<title>New Mayor vows to raise issue awareness</title>
<link>http://health.einnews.com/news.php?wid=170201585</link>
<pubDate>16 May 2008 11:42 GMT</pubDate>
<description>
...  care and commitment. Coun O&apos;Brien raised more than 63,000 for his chosen charity, Breast Cancer Services, during his year as mayor. He was also praised for the fair way  ...
</description>
</item><item>
<title>Glitzy evening helps cancer unit</title>
<link>http://health.einnews.com/news.php?wid=170201553</link>
<pubDate>16 May 2008 11:42 GMT</pubDate>
<description>
...  took part in a Gowns and Glitter evening to raise funds for the Teenage Cancer Unit at St James&apos;s Hospital in Leeds. More than 900 was raised from the  ...
</description>
</item><item>
<title>Charity scheme to draw up free wills</title>
<link>http://health.einnews.com/news.php?wid=170201552</link>
<pubDate>16 May 2008 11:42 GMT</pubDate>
<description>
...  charities sponsoring Free Wills Fortnight are Age Concern, Barnardos, The Blue Cross, Breakthrough Breast Cancer, CAFOD, RNID, RNLI and The Stroke Association. For more details and a list of  ...
</description>
</item><item>
<title>Lack of Vitamin D Linked to Breast Cancer</title>
<link>http://health.einnews.com/news.php?wid=170201453</link>
<pubDate>16 May 2008 11:40 GMT</pubDate>
<description>
... Lack of Vitamin D Linked to Breast Cancer Researchers at the University of California, San Diego, say they have shown a clear  ...
</description>
</item><item>
<title>Brown condemns fan violence</title>
<link>http://health.einnews.com/news.php?wid=170201448</link>
<pubDate>16 May 2008 11:40 GMT</pubDate>
<description>
...  before holding coaching roles at the club including manager, has died after fighting skin cancer, the club said yesterday. He was 51. Burns played for Celtic from 1975 to  ...
</description>
</item><item>
<title>Azor(TM) Reduces Blood Pressure In Difficult To Treat Special Populations</title>
<link>http://health.einnews.com/news.php?wid=170201396</link>
<pubDate>16 May 2008 11:40 GMT</pubDate>
<description>
...  the discovery of new medicines in the areas of glucose metabolic disorders, infectious diseases, cancer, bone and joint diseases, and immune disorders. For more information, please visit . SeDBP  ...
</description>
</item><item>
<title>IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program</title>
<link>http://health.einnews.com/news.php?wid=170201393</link>
<pubDate>16 May 2008 11:40 GMT</pubDate>
<description>
...  osteosarcoma, a rare and often fatal bone tumor that typically affects children and young adults.  ...  principal investigator and professor of pediatrics, Children&apos;s Cancer Hospital at The University of Texas M.  ...
</description>
</item><item>
<title>Schering-Plough Highlights PEGINTRON(TM) And Boceprevir Hepatitis C Data Presentations At Digestive Disease Week (DDW) Annual Meeting</title>
<link>http://health.einnews.com/news.php?wid=170201388</link>
<pubDate>16 May 2008 11:40 GMT</pubDate>
<description>
...  the leading cause of cirrhosis and liver cancer, and the number one reason for liver  ...  mutagenic and should be considered a potential carcinogen Contraindications PEGINTRON is contraindicated in patients with  ...
</description>
</item><item>
<title>Cervarix(TM) Provides Longest Duration Of Sustained Neutralising Antibodies Reported For Any Vaccine Against HPV 16 And 18 Date</title>
<link>http://health.einnews.com/news.php?wid=170201387</link>
<pubDate>16 May 2008 11:40 GMT</pubDate>
<description>
...  CervarixTM generates sustained high levels of neutralising antibodies against the two most common cervical cancer-causing virus types for up to 6.4 years.4 This is the longest duration of sustained  ...
</description>
</item><item>
<title>Eribulin Mesylate Demonstrated Anti-Tumor Activity In Heavily Pretreated Patients With Advanced Breast Cancer</title>
<link>http://health.einnews.com/news.php?wid=170201386</link>
<pubDate>16 May 2008 11:40 GMT</pubDate>
<description>
...  women with locally advanced or metastatic breast cancer, according to results of a multi-center Phase  ...  S Hall A1 of McCormick Place. &quot;The anti-tumor activity of eribulin mesylate, as observed in  ...
</description>
</item></channel>
</rss>
